These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33991536)

  • 1. Monoclonal free light chain detection and quantification: Performances and limits of available laboratory assays.
    Sarto C; Intra J; Fania C; Brivio R; Brambilla P; Leoni V
    Clin Biochem; 2021 Sep; 95():28-33. PubMed ID: 33991536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines for the analysis of Bence Jones protein.
    Graziani M; Merlini G; Petrini C; ;
    Clin Chem Lab Med; 2003 Mar; 41(3):338-46. PubMed ID: 12705344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of Bence Jones proteins by immunonephelometry.
    Levinson SS
    Ann Clin Lab Sci; 1992; 22(2):100-9. PubMed ID: 1562164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new concept for detection of Bence Jones proteinuria in patients with monoclonal gammopathy.
    Hofmann W; Garbrecht M; Bradwell AR; Guder WG
    Clin Lab; 2004; 50(3-4):181-5. PubMed ID: 15074473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Free light chains assay: Indications and methods].
    Martellosio JP; Leleu X; Roblot P; Martin M; Puyade M
    Rev Med Interne; 2019 May; 40(5):297-305. PubMed ID: 30862366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays.
    Katzmann JA; Dispenzieri A; Kyle RA; Snyder MR; Plevak MF; Larson DR; Abraham RS; Lust JA; Melton LJ; Rajkumar SV
    Mayo Clin Proc; 2006 Dec; 81(12):1575-8. PubMed ID: 17165636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can serum free light chains replace urine electrophoresis in the detection of monoclonal gammopathies?
    Beetham R; Wassell J; Wallage MJ; Whiteway AJ; James JA
    Ann Clin Biochem; 2007 Nov; 44(Pt 6):516-22. PubMed ID: 17961305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of serum free light chain analysis and urine protein electrophoresis for detection of monoclonal gammopathies.
    Holding S; Spradbery D; Hoole R; Wilmot R; Shields ML; Levoguer AM; Doré PC
    Clin Chem Lab Med; 2011 Jan; 49(1):83-8. PubMed ID: 20961192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunochemical quantification of free immunoglobulin light chains from an analytical perspective.
    Nakano T; Miyazaki S; Takahashi H; Matsumori A; Maruyama T; Komoda T; Nagata A
    Clin Chem Lab Med; 2006; 44(5):522-32. PubMed ID: 16681419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum free light chains in the diagnosis and monitoring of patients with plasma cell dyscrasias.
    Mayo MM; Johns GS
    Contrib Nephrol; 2007; 153():44-65. PubMed ID: 17075223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative analysis of immunoglobulin free light chains quantification by Freelite™ (The Binding Site) and N Latex FLC (Siemens) methods].
    Schneider N; Wynckel A; Kolb B; Sablon E; Gillery P; Maquart FX
    Ann Biol Clin (Paris); 2013; 71(1):13-9. PubMed ID: 23396425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The significance of analysis and detection of Bence Jones protein in the urine in clinical laboratory diagnosis].
    Végh Z; Ottó S
    Orv Hetil; 1989 Aug; 130(35):1871-5. PubMed ID: 2507996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How lab staff and the estimation of free light chains can combine to aid the diagnosis of light chain disease.
    Sinclair D; Wainwright L
    Clin Lab; 2007; 53(5-6):267-71. PubMed ID: 17605400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strengths and weaknesses of methods for identifying monoclonal free light chains of Ig: examples from two cases with renal disease.
    Levinson SS
    Clin Chem Lab Med; 2016 Jun; 54(6):1039-43. PubMed ID: 26368046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum free light chains in clinical laboratory diagnostics.
    Jenner E
    Clin Chim Acta; 2014 Jan; 427():15-20. PubMed ID: 23999048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical applications of immunoglobulin free light chain analysis.
    Pascali E
    Int J Clin Lab Res; 1994; 24(2):120-1. PubMed ID: 7919429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory investigation of monoclonal gammopathy during 10 years of screening in a general hospital.
    Malacrida V; De Francesco D; Banfi G; Porta FA; Riches PG
    J Clin Pathol; 1987 Jul; 40(7):793-7. PubMed ID: 3114329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Usefulness of a free light chain immunoassay in serum for the diagnosis and the follow-up of monoclonal gammopathy].
    Guenet L; Decaux O; Lechartier H; Ropert M; Grosbois B
    Rev Med Interne; 2007 Oct; 28(10):689-97. PubMed ID: 17566612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter-assay variability in automated serum free light chain assays and their use in the clinical laboratory.
    Caponi L; Romiti N; Koni E; Fiore AD; Paolicchi A; Franzini M
    Crit Rev Clin Lab Sci; 2020 Mar; 57(2):73-85. PubMed ID: 31612753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical Criticalities Associated to Different Immunological Methods for Serum Free Light Chain Detection in Plasma Cell Dyscrasias: A Description of Particular Clinical Cases.
    Sabatino R; Perrone A; Cuomo M; Liotti S; Barchiesi V; Cantile M; Cavalcanti E
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.